Mole study aims to personalize melanoma screening

NCT ID NCT03080948

Completed Knowledge-focused Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 73 people with many moles to see if certain mole features can help predict who is most likely to develop melanoma. Participants gave saliva samples and had their moles photographed and analyzed. The goal is to improve risk assessment and make melanoma screening more personalized.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better identify who is at highest risk for melanoma and tailor screening to each person.
What could go wrong: This is a small, observational study that only looks at patterns, not a treatment. The findings may not apply to everyone and need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIGH-RISK NEVUS PHENOTYPE

Contacts and locations

Show contact details

Locations

Memorial Sloan Kettering Basking Ridge

Basking Ridge, New Jersey, 07920, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Memorial Sloan Kettering Cancer Center Hauppauge

Hauppauge, New York, 11788, United States
Memorial Sloan Kettering Westchester

Harrison, New York, 10604, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.